RCF-CL , Mrp : 210.00 / 10 Tablet

Is a broad-spectrum antibiotic combination formulated to treat a wide range of bacterial infections. It combines Cefixime, a third-generation cephalosporin antibiotic, with Potassium Clavulanate, a beta-lactamase inhibitor that enhances the effectiveness of Cefixime against resistant bacteria.
Therapeutic Indications

• Respiratory tract infections
• Ear, Nose, and Throat (ENT) infections
• Urinary tract infections (UTIs)
• Skin and soft tissue infections
• Bronchitis and lower respiratory tract infections
• Typhoid fever and other susceptible bacterial infections (as prescribed by a physician)
  Mechanism of Action Cefixime

• Inhibits bacterial cell wall synthesis
• Kills susceptible bacteria and prevents infection spread
• Effective against a broad range of gram-positive and gram-negative organisms
  Potassium Clavulanate

• Inhibits beta-lactamase enzymes produced by resistant bacteria
• Protects Cefixime from bacterial degradation
• Enhances antibacterial effectiveness and spectrum of action
  Dosage To be taken strictly as directed by the physician.